bioAffinity Technologies Raises $1.2 Million through Private Placement and Warrant Inducement Transactions

bioAffinity Technologies has closed private placement and warrant inducement transactions, raising approximately $1.2 million. The transactions included the sale of 990 shares of Series B Convertible Preferred Stock and warrants to purchase 6.7 million shares of common stock. WallachBeth Capital LLC served as the sole placement agent and financial advisor. The company also closed a warrant inducement transaction with an existing investor, generating $253,000 in gross cash proceeds.

bioAffinity Technologies has successfully closed its private placement and warrant inducement transactions, raising approximately $1.2 million in gross proceeds. The company's Series B Convertible Preferred Stock and warrants were sold in the transaction, with WallachBeth Capital LLC acting as the sole placement agent and financial advisor.

The private placement involved the sale of 990 shares of Series B Convertible Preferred Stock and warrants to purchase approximately 6.7 million shares of common stock. Additionally, the company closed a warrant inducement transaction with an existing accredited investor, generating $253,000 in gross cash proceeds.

The securities offered in the private placement were exempt from registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended, and Regulation D promulgated thereunder. As a result, the securities may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Act and applicable state securities laws.

WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, has a robust range of services for the healthcare community, connecting corporate clients with leading institutions and supporting issuers and investors in achieving their financial goals. The firm's experience includes initial public offerings, follow-on issues, PIPE offerings, and private transactions.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

References:
[1] WallachBeth Capital Announces Closing of bioAffinity Technologies Private Placement and Concurrent Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds. (2025, August 14). PR Newswire. Retrieved from https://www.morningstar.com/news/pr-newswire/20250814ny52096/wallachbeth-capital-announces-closing-of-bioaffinity-technologies-private-placement-and-concurrent-warrant-inducement-transaction-for-approximately-12-million-in-gross-proceeds